Xencor
XNCR
#5582
Rank
A$1.86 B
Marketcap
A$26.06
Share price
-4.63%
Change (1 day)
-33.81%
Change (1 year)

Xencor (XNCR) - Cash on Hand

Cash on Hand as of September 2025 : A$0.70 Billion

According to Xencor's latest financial reports the company has A$0.70 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Xencor - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.80 B-8.17%
2023-12-31A$0.87 B-4.82%
2022-12-31A$0.91 B98.67%
2021-12-31A$0.46 B-41.23%
2020-12-31A$0.78 B3.64%
2019-12-31A$0.75 B81.09%
2018-12-31A$0.41 B45.55%
2017-12-31A$0.28 B59.02%
2016-12-31A$0.18 B36.39%
2015-12-31A$0.13 B98.23%
2014-12-31A$66.77 M-23.61%
2013-12-31A$87.41 M3829.26%
2012-12-31A$2.22 M-84.31%
2011-12-31A$14.17 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Seagen
SGEN
A$1.86 B 162.61%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
A$0.22 B-68.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.22 B 1,905.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$27.44 B 3,766.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$27.96 B 3,840.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.54 B 1,103.92%๐Ÿ‡บ๐Ÿ‡ธ USA